226 related articles for article (PubMed ID: 10320225)
1. Type of lymph node involvement and survival in pathologic N1 stage III non-small cell lung carcinoma.
van Velzen E; de la Rivière AB; Elbers HJ; Lammers JW; van den Bosch JM
Ann Thorac Surg; 1999 Apr; 67(4):903-7. PubMed ID: 10320225
[TBL] [Abstract][Full Text] [Related]
2. Type of lymph node involvement influences survival rates in T1N1M0 non-small cell lung carcinoma. Lymph node involvement by direct extension compared with lobar and hilar node metastases.
van Velzen E; Snijder RJ; Brutel de la Rivière A; Elbers HJ; van den Bosch JM
Chest; 1996 Dec; 110(6):1469-73. PubMed ID: 8989063
[TBL] [Abstract][Full Text] [Related]
3. Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinoma.
van Velzen E; Snijder RJ; Brutel de la Rivière A; Elbers HR; van den Bosch JM
Ann Thorac Surg; 1997 May; 63(5):1436-40. PubMed ID: 9146339
[TBL] [Abstract][Full Text] [Related]
4. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung.
Matsuoka K; Sumitomo S; Misaki N
J Thorac Oncol; 2007 Dec; 2(12):1098-102. PubMed ID: 18090581
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
[TBL] [Abstract][Full Text] [Related]
7. Extent of lung resection in non-small lung cancer with interlobar lymph node involvement.
Gunluoglu MZ; Demir A; Turna A; Sansar D; Melek H; Dincer SI; Gurses A
Ann Thorac Cardiovasc Surg; 2011; 17(3):229-35. PubMed ID: 21697782
[TBL] [Abstract][Full Text] [Related]
8. Prognostic variability among nonsmall cell lung cancer patients with pathologic N1 lymph node involvement. Epidemiological figures with strong clinical implications.
Caldarella A; Crocetti E; Comin CE; Janni A; Pegna AL; Paci E
Cancer; 2006 Aug; 107(4):793-8. PubMed ID: 17024758
[TBL] [Abstract][Full Text] [Related]
9. Pneumonectomy vs lobectomy in the treatment of pathologic N1 NSCLC: could the type of surgical resection dictate survival?
Luzzi L; Voltolini L; Campione A; Paladini P; Ghiribelli C; Di Bisceglie M; Gotti G
J Cardiovasc Surg (Torino); 2003 Feb; 44(1):119-23. PubMed ID: 12627083
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung.
Riquet M; Manac'h D; Le Pimpec-Barthes F; Dujon A; Chehab A
Ann Thorac Surg; 1999 Jun; 67(6):1572-6. PubMed ID: 10391257
[TBL] [Abstract][Full Text] [Related]
11. Frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma.
Bonner JA; Garces YI; Sawyer TE; Gould PM; Foote RL; Deschamps C; Lange CM; Li H
Cancer; 1999 Oct; 86(7):1159-64. PubMed ID: 10506699
[TBL] [Abstract][Full Text] [Related]
12. [Significance of pulmonary lymph node metastases in locally advanced non-small cell lung cancer].
Marra A; Hillejan L; Pöttgen C; Zaboura G; Fechner S; Greschuchna D; Stamatis G
Pneumologie; 2002 Dec; 56(12):773-80. PubMed ID: 12486615
[TBL] [Abstract][Full Text] [Related]
13. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
[TBL] [Abstract][Full Text] [Related]
14. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer.
Osaki T; Nagashima A; Yoshimatsu T; Tashima Y; Yasumoto K
Lung Cancer; 2004 Feb; 43(2):151-7. PubMed ID: 14739035
[TBL] [Abstract][Full Text] [Related]
15. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy?
Asamura H; Nakayama H; Kondo H; Tsuchiya R; Shimosato Y; Naruke T
J Thorac Cardiovasc Surg; 1996 Jun; 111(6):1125-34. PubMed ID: 8642812
[TBL] [Abstract][Full Text] [Related]
16. Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes.
Yano T; Yokoyama H; Inoue T; Asoh H; Tayama K; Ichinose Y
J Thorac Cardiovasc Surg; 1994 Jun; 107(6):1398-402. PubMed ID: 8196379
[TBL] [Abstract][Full Text] [Related]
17. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
18. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
Park S; Cho S; Yum SW; Kim K; Jheon S
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status.
Maeshima AM; Tsuta K; Asamura H; Tsuda H
Cancer; 2012 Sep; 118(18):4512-8. PubMed ID: 22282325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
